• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.41 0.13(2.46%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:5.28
    Open:5.45
    Bid:5.25 x 100
    Ask:N/A
    1y Target Est:11.17
    Beta:3.79
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:5.32 - 5.68
    52wk Range:3.11 - 7.82
    Volume:5,406,279
    Avg Vol (3m):3,122,680
    Market Cap:666.33M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 2.46%666.33M
    ABT66.04B
    GSK108.20B
    RHHBYN/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.12
    Quarterly EPS Est (Dec-14) :0.21
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-2.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback